United States Mammography and Breast Imaging Market Outlook Report 2022-2025 with Hologic, GE HealthCare and Siemens Healthineers Dominating

In This Article:

Company Logo
Company Logo

Dublin, April 05, 2023 (GLOBE NEWSWIRE) -- The "2022 U.S Mammography and Breast Imaging Market Outlook Report" report has been added to ResearchAndMarkets.com's offering.

Mammography departments are anticipating that their current budgets will grow by an estimated 9.7% per year from 2023 through 2025, according to the 2022 Mammography and Breast Imaging Market Outlook Report.

For the first time in over a decade, the analyst has relaunched coverage of mammography and breast imaging in its popular market outlook series. According to the 2022 survey of mammography departments, the top five priorities of mammography departments are as follows:

  • Improve patient satisfaction with their mammography experience.

  • Obtain/maintain mammography department accreditation.

  • Improve staff satisfaction and morale.

  • Better cancer detection for dense breast screening.

  • Satisfy the needs of referring physicians.

As indicated by respondents, the impact of the COVID-19 pandemic on mammography departments peaked in 2020 and is now at the lowest level since that time. The peak impact occurred in 2020 with 87% of departments experiencing a medium or high impact from the pandemic with an average rating of 8.6/10, with 10 being the highest impact. At the time of the survey in the fall of 2022, 21% of sites continued to experience a medium or high impact with an average rating of 4.1/10.

In the 2022 survey, an estimated 91% of 400+ bed hospitals, 64% of nonhospitals, 53% of 200-399 bed hospitals, and 14% of < 200-bed hospitals performed over 6,000 annual mammography procedures per site. In 2022 overall, 25% of mammography procedures were performed for diagnostic purposes and 75% for screening purchases. Mammography-related biopsies are collected at 75% of facilities.

According to the 2022 survey, Hologic has the largest mammography installed base share with 69% followed by GE HealthCare with 20%, Siemens Healthineers with 8%, Fujifilm Healthcare Americas with 1%, and Philips with < 1%.

After a 17% decline in 2022, mammography department budgets are anticipated to grow an estimated 9.7% each year from 2023 through 2025, for sites with a nonzero budget. Regarding mammography system purchase plans, 36% of sites are "Yes, Planning" or "Maybe Planning" to purchase systems over the next three years.

Despite the popularity of the topic, 63% of mammography sites are not currently using artificial intelligence (AI). For sites that are using AI, the most common uses of AI technology in mammography practices are for clinical support to radiologists in diagnostic interpretations, first-pass screening for lesions, to improve image quality output and workflow optimization.